Aggressive adriamycin‐containing regimen (PM‐FAC) in estrogen receptor‐negative disseminated breast cancer. Results of a southwest oncology group trial

Joanne Mortimer, Nancy Flournoy, Robert B. Livingston, Ronald L. Stephens

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Aggressive adriamycin‐containing regimen (PM‐FAC) in estrogen receptor‐negative disseminated breast cancer. Results of a southwest oncology group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences